Northside Hospital BMT Program ‘significantly’ exceeds expected survival rates for 11th year
7/15/2020, Northside Hospital
For an 11th consecutive year, the Blood and Marrow Transplant (BMT) Program at Northside Hospital Cancer Institute has been recognized as having among the best survival outcomes in the United States for bone marrow transplants.
The data was reported in the Center for International Blood and Marrow Transplant Research Final 2019 Transplant Center Survival Report and from Be The Match®.
One hundred seventy adult and pediatric transplant centers were included in the analysis of patients who received their first allogeneic transplant between January 1, 2015 and December 31, 2017 using unrelated or related donors and who had reported follow-up. The one-year survival of patients transplanted at Northside was 81.1%.
Northside is one of only two adult BMT programs in the U.S. that has achieved survival outcomes that significantly exceeded their expected survival rate for the last 11 consecutive annual reporting cycles, and Northside is the only program in Georgia to over perform.
“The BMT Program at Northside is the largest allogeneic transplant program in Georgia,” said H. Kent Holland, M.D., medical director of the BMT Program at Northside Hospital Cancer Institute. “Our success is a direct reflection of the combined experience and expertise of the teams in our inpatient and outpatient BMT units, our stem-cell laboratory and blood donor center.”